Hippo Holdings Inc. (HIPO) 10-Year Financial Performance & Capital Metrics

HIPO • • Insurance & Managed Care

Financial ServicesSpecialty InsuranceSpecialty Property & Casualty InsuranceExcess & Surplus Lines Insurers

AboutHippo Holdings Inc. provides home protection insurance in the United States and the District of Columbia. Its insurance products include homeowners' insurance against risks of fire, wind, and theft; and commercial and personal lines of products. The company distributes insurance products and services through its technology platform; and offers its policies online, over the phone, or through licensed insurance agents. It provides care and protection for homeowners, as well as operates an integrated home protection platform. The company is headquartered in Palo Alto, California.Show more

Revenue $372M +77.4%
Combined Ratio 107.36% -52.3%
Net Income -$41M +85.2%
Return on Equity -10.8% +80.7%
Medical Cost Ratio 80.03% -42.7%
Operating Margin -7.36% +94.1%
Net Margin -10.88% +91.6%
ROA -2.64% +85.0%
Equity / Assets 23.66% -6.2%
Book Value per Share 14.79 -9.4%
Tangible BV/Share 12.15 -7.3%
Debt/Equity 0.03 -28.8%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 7/9

✗Weaknesses

✗Unprofitable underwriting: 107.4% combined ratio
✗High loss ratio of 80.0%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y60.72%

3Y59.79%

TTM34.48%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM175.51%

EPS CAGR

10Y-

5Y-

3Y-

TTM171.15%

ROCE

10Y Avg-24%

5Y Avg-19.37%

3Y Avg-13.13%

Latest-2.16%

Peer Comparison

Excess & Surplus Lines Insurers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AIZAssurant, Inc.	11.89B	237.45	16.42	6.7%	6.75%	14.74%	9.35%	0.41
JRVRJames River Group Holdings, Ltd.	307.51M	6.69	-2.19	-12.85%	-7.64%	-7.76%		0.51
HIPOHippo Holdings Inc.	773.74M	30.54	-18.62	77.44%	21.31%	22.75%	6.1%	0.03

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	34.7M	51.6M	91.2M	119.7M	209.7M	372.1M
Revenue Growth %	-	0.49%	0.77%	0.31%	0.75%	0.77%
Medical Costs & Claims+	0	35M	105.9M	179.1M	293.1M	297.8M
Medical Cost Ratio %	-	-	-	-	-	-
Gross Profit+	34.7M	16.6M	-14.7M	-59.4M	-83.4M	74.3M
Gross Margin %	-	-	-	-	-	-
Gross Profit Growth %	-	-0.52%	-1.89%	-3.04%	-0.4%	1.89%
Operating Expenses+	106.5M	159.8M	352.5M	265.8M	179.1M	101.7M
OpEx / Revenue %	-	-	-	-	-	-
Depreciation & Amortization	0	6.7M	11M	15.2M	19.8M	23.2M
Combined Ratio %	-	-	-	-	-	-
Operating Income+	-71.8M	-143.2M	-367.2M	-325.2M	-262.5M	-27.4M
Operating Margin %	-	-	-	-	-	-
Operating Income Growth %	-	-0.99%	-1.56%	0.11%	0.19%	0.9%
EBITDA+	-71.8M	-136.5M	-356.2M	-310M	-242.7M	-4.2M
EBITDA Margin %	-	-	-	-	-	-
Interest Expense	0	26M	198.9M	0	0	0
Non-Operating Income	-71.8M	-26M	-198.9M	0	0	0
Pretax Income+	-83M	-143.2M	-367.2M	-325.2M	-262.5M	-27.4M
Pretax Margin %	-	-	-	-	-	-
Income Tax+	100K	-1.8M	700K	1.3M	500K	1.2M
Effective Tax Rate %	-	-	-	-	-	-
Net Income+	-83.1M	-141.5M	-371.4M	-333.4M	-273.1M	-40.5M
Net Margin %	-	-	-	-	-	-
Net Income Growth %	-	-0.7%	-1.62%	0.1%	0.18%	0.85%
EPS (Diluted)+	-171.52	-40.68	-23.77	-14.35	-11.58	-1.64
EPS Growth %	-	0.76%	0.42%	0.4%	0.19%	0.86%
EPS (Basic)	-171.52	-40.68	-23.77	-14.35	-11.58	-1.64
Diluted Shares Outstanding	484.49K	3.48M	15.48M	22.75M	23.58M	24.7M

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	170.5M	979.4M	1.64B	1.57B	1.52B	1.54B
Asset Growth %	-	4.74%	0.68%	-0.04%	-0.03%	0.01%
Total Investment Assets+	0	56M	73.1M	445.9M	348.8M	0
Long-Term Investments	0	56M	64M	445.9M	348.8M	0
Short-Term Investments	0	0	9.1M	445.9M	348.8M	0
Total Current Assets+	23.3M	0	1.15B	0	0	364.6M
Cash & Equivalents	23.3M	452.3M	775.6M	194.5M	142.1M	197.6M
Receivables	0	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	-774.2M	0	-1.42B	-1.34B	0
Goodwill & Intangibles+	25.3M	96.4M	111.6M	65.7M	75.7M	65.1M
Goodwill	1.9M	47.8M	53.5M	0	0	0
Intangible Assets	23.4M	48.6M	58.1M	65.7M	75.7M	65.1M
PP&E (Net)	900K	0	1.1M	33M	45.5M	37.7M
Other Assets	121M	-152.4M	-175.6M	-544.6M	-470M	-85.8M
Total Liabilities	18.2M	1.18B	781M	975.4M	1.14B	1.18B
Total Debt+	0	273M	0	28.9M	14.8M	10M
Net Debt	-23.3M	-179.3M	-775.6M	-165.6M	-127.3M	-187.6M
Long-Term Debt	0	273M	0	0	0	0
Short-Term Debt	0	0	0	0	0	0
Total Current Liabilities+	18.2M	0	182.6M	0	0	267.9M
Accounts Payable	0	96M	182.6M	234.8M	286.4M	267.9M
Deferred Revenue	0	0	0	0	0	0
Other Current Liabilities	0	-103.5M	-182.6M	-241M	-293.7M	0
Deferred Taxes	0	0	0	0	0	0
Other Liabilities	0	-279.1M	0	-50.1M	-28.4M	892.3M
Total Equity+	118.7M	-199.5M	861.7M	593.5M	384.7M	365.2M
Equity Growth %	-	-2.68%	5.32%	-0.31%	-0.35%	-0.05%
Shareholders Equity	118.7M	-199.6M	859.6M	589.9M	377.9M	362.1M
Minority Interest	0	100K	2.1M	3.6M	6.8M	3.1M
Retained Earnings	-115.1M	-256.6M	-628M	-961.1M	-1.23B	-1.27B
Common Stock	0	0	0	0	0	0
Accumulated OCI	100K	100K	-700K	-7M	-2.9M	-2.7M
Return on Equity (ROE)	-0.7%	-	-1.12%	-0.46%	-0.56%	-0.11%
Return on Assets (ROA)	-0.49%	-0.25%	-0.28%	-0.21%	-0.18%	-0.03%
Equity / Assets	-	-	-	-	-	-
Debt / Equity	-	-	-	0.05x	0.04x	0.03x
Book Value per Share	245.00	-57.39	55.68	26.09	16.32	14.79
Tangible BV per Share	-	-	-	-	-	-

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-29.1M	-65.4M	-124.5M	-161.5M	-92.4M	47.5M
Operating CF Growth %	-	-1.25%	-0.9%	-0.3%	0.43%	1.51%
Operating CF / Revenue %	-	-	-	-	-	-
Net Income	-83.1M	-141.4M	-367.9M	-326.5M	-273.1M	-28.6M
Depreciation & Amortization	2.9M	6.7M	11M	15.2M	19.8M	23.2M
Stock-Based Compensation	21.9M	17.2M	24.3M	61.9M	57.5M	38.2M
Deferred Taxes	0	0	0	0	0	0
Other Non-Cash Items	2.8M	27.1M	164.4M	50.6M	10.1M	-55.6M
Working Capital Changes	26.4M	25M	43.7M	37.3M	93.3M	70.3M
Cash from Investing+	-72.3M	-2.3M	-30M	-405.9M	57.6M	30.3M
Capital Expenditures	-900K	-400K	-800K	-19.7M	-29.6M	-300K
Acquisitions	-600K	-83.7M	-600K	0	0	0
Purchase of Investments	0	-16.7M	-26.2M	-793M	-409.6M	-367.8M
Sale/Maturity of Investments	0	1000K	1000K	1000K	1000K	1000K
Other Investing	-70.8M	-9M	-18.9M	-2M	-20.3M	61.5M
Cash from Financing+	101.4M	518.1M	480.8M	-6.8M	-14.6M	-40.1M
Dividends Paid	0	0	0	0	0	0
Share Repurchases	0	0	0	0	-1.8M	-15.6M
Stock Issued	0	0	0	4.1M	2.8M	6.7M
Debt Issuance (Net)	0	1000K	0	0	0	0
Other Financing	101.4M	-1.5M	480.8M	-10.9M	-15.6M	-31.2M
Net Change in Cash+	42M	450.4M	326.3M	-574.2M	-49.4M	37.7M
Exchange Rate Effect	0	0	0	0	0	0
Cash at Beginning	0	42M	492.4M	818.7M	244.5M	195.1M
Cash at End	42M	492.4M	818.7M	244.5M	195.1M	232.8M
Free Cash Flow+	-30M	-74.8M	-141.9M	-181.2M	-139.1M	47.2M
FCF Growth %	-	-1.49%	-0.9%	-0.28%	0.23%	1.34%
FCF Margin %	-	-	-	-	-	-
FCF per Share	-61.92	-21.52	-9.17	-7.97	-5.9	1.91

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Combined Ratio	306.92%	377.52%	502.63%	371.68%	225.18%	107.36%
Medical Cost Ratio	0%	67.83%	116.12%	149.62%	139.77%	80.03%
Return on Equity (ROE)	-70.01%	-	-112.17%	-45.82%	-55.84%	-10.8%
Return on Assets (ROA)	-48.74%	-24.61%	-28.33%	-20.76%	-17.66%	-2.64%
Equity / Assets	69.62%	-20.37%	52.46%	37.83%	25.23%	23.66%
Book Value / Share	245	-57.39	55.68	26.09	16.32	14.79
Debt / Equity	-	-	-	0.05x	0.04x	0.03x
Revenue Growth	-	48.7%	76.74%	31.25%	75.19%	77.44%

Revenue by Segment

	2023	2024
Services	44.3M	48.2M
Services Growth	-	8.80%

Revenue by Geography

	2023	2024
Services	44.3M	48.2M
Services Growth	-	8.80%

Frequently Asked Questions

Growth & Financials

Hippo Holdings Inc. (HIPO) grew revenue by 77.4% over the past year. This is strong growth.

Yes, Hippo Holdings Inc. (HIPO) is profitable, generating $95.9M in net income for fiscal year 2024 (-10.9% net margin).

Dividend & Returns

Hippo Holdings Inc. (HIPO) has a return on equity (ROE) of -10.8%. Negative ROE indicates the company is unprofitable.

Industry Metrics

Hippo Holdings Inc. (HIPO) has a combined ratio of 107.4%. A ratio above 100% means claims and expenses exceed premiums.

← Back to Screener